Rare Diseases
News from the FDA/CDC
FDA approves rituximab to treat children with rare vasculitis
From the Journals
USPSTF: Screening pregnant women for asymptomatic bacteriuria cuts pyelonephritis risk
But the new recommendations urge clinicians to refrain from testing asymptomatic nonpregnant women and adult men.
From the Journals
New genotype of S. pyrogenes found in rise of scarlet fever in U.K.
From the Journals
Possible role of enterovirus infection in acute flaccid myelitis cases detected
High levels of enterovirus peptides were found in the cerebral spinal fluid of individuals with AFM.
Conference Coverage
Hospital slashes S. aureus vancomycin resistance
LJUBLJANA, SLOVENIA – Staphylococcus aureus resistance to vancomycin is not a one-way street ending in a cliff plunge.
Latest News
NIH launches 5-year, $10 million study on acute flaccid myelitis
Researchers at the University of Alabama at Birmingham will lead the study, which aims to examine the natural history, incidence, and risk factors...
Conference Coverage
CDC: Look for early symptoms of acute flaccid myelitis, report suspected cases
The average age of a patient diagnosed with AFM is 5 years
Video
Efforts toward producing CNO/CRMO classification criteria show first results
MADRID – Cases are now being accepted for inclusion into a repository that will be used to develop and validate criteria.
Opinion
A longing for belonging
Dr. Wilkoff explains how giving a patient a diagnosis fills a longing for belonging.
Latest News
New tickborne virus emerges in China
A previously unknown RNA segmented virus was associated with a febrile illness that spread to 86 patients.
News
FDA approves Zolgensma for infantile-onset SMA treatment
Zolgensma is the first gene therapy for the treatment of infantile-onset spinal muscular atrophy in children aged less than 2 years.